Feasibility study of Glucagon-like peptide-1 analogues for the optimization of Outcomes in obese patients undergoing AbLation for Atrial Fibrillation (GOAL-AF) protocol.
Kyaw Z WinMatthew ArmstrongRichard P SteedsManish KallaPublished in: Pilot and feasibility studies (2024)
Metchley Park Medical Society and University of Birmingham Starter Fellowship, British Heart Foundation Accelerator Grant, Abbott Investigator-Initiated Study Grant.
Keyphrases
- atrial fibrillation
- patients undergoing
- catheter ablation
- heart failure
- left atrial
- randomized controlled trial
- adipose tissue
- healthcare
- metabolic syndrome
- oral anticoagulants
- left atrial appendage
- type diabetes
- weight loss
- direct oral anticoagulants
- percutaneous coronary intervention
- molecular docking
- obese patients
- bariatric surgery
- coronary artery disease
- venous thromboembolism
- left ventricular